These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 27749281)

  • 21. Modeling local and global intracellular calcium responses mediated by diffusely distributed inositol 1,4,5-trisphosphate receptors.
    Williams GS; Molinelli EJ; Smith GD
    J Theor Biol; 2008 Jul; 253(1):170-88. PubMed ID: 18405920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Understanding IP
    Baker MR; Fan G; Arige V; Yule DI; Serysheva II
    Cell Calcium; 2023 Sep; 114():102770. PubMed ID: 37393815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conformational motions and ligand-binding underlying gating and regulation in IP
    Fan G; Baker MR; Terry LE; Arige V; Chen M; Seryshev AB; Baker ML; Ludtke SJ; Yule DI; Serysheva II
    Nat Commun; 2022 Nov; 13(1):6942. PubMed ID: 36376291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A data-driven model of a modal gated ion channel: the inositol 1,4,5-trisphosphate receptor in insect Sf9 cells.
    Ullah G; Mak DO; Pearson JE
    J Gen Physiol; 2012 Aug; 140(2):159-73. PubMed ID: 22851676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural organization of signalling to and from IP3 receptors.
    Taylor CW; Tovey SC; Rossi AM; Lopez Sanjurjo CI; Prole DL; Rahman T
    Biochem Soc Trans; 2014 Feb; 42(1):63-70. PubMed ID: 24450629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. All three IP
    Lock JT; Alzayady KJ; Yule DI; Parker I
    Sci Signal; 2018 Dec; 11(561):. PubMed ID: 30563861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural basis for activation and gating of IP
    Schmitz EA; Takahashi H; Karakas E
    Nat Commun; 2022 Mar; 13(1):1408. PubMed ID: 35301323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bcl-xL acts as an inhibitor of IP
    Rosa N; Ivanova H; Wagner LE; Kale J; La Rovere R; Welkenhuyzen K; Louros N; Karamanou S; Shabardina V; Lemmens I; Vandermarliere E; Hamada K; Ando H; Rousseau F; Schymkowitz J; Tavernier J; Mikoshiba K; Economou A; Andrews DW; Parys JB; Yule DI; Bultynck G
    Cell Death Differ; 2022 Apr; 29(4):788-805. PubMed ID: 34750538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathophysiological consequences of isoform-specific IP
    Kerkhofs M; Seitaj B; Ivanova H; Monaco G; Bultynck G; Parys JB
    Biochim Biophys Acta Mol Cell Res; 2018 Nov; 1865(11 Pt B):1707-1717. PubMed ID: 29906486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of IP
    Taylor CW
    Cell Calcium; 2017 May; 63():48-52. PubMed ID: 27836216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A kinetic Monte Carlo simulation study of inositol 1,4,5-trisphosphate receptor (IP3R) calcium release channel.
    Haeri HH; Hashemianzadeh SM; Monajjemi M
    Comput Biol Chem; 2007 Apr; 31(2):99-109. PubMed ID: 17392027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tetrameric, active PKM2 inhibits IP
    Lemos FO; de Ridder I; Wagner L; Bootman MD; Bultynck G; Yule DI; Parys JB
    Biochim Biophys Acta Mol Cell Res; 2024 Oct; 1871(7):119796. PubMed ID: 39038610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IP
    Parys JB; Bultynck G; Vervliet T
    Prog Mol Subcell Biol; 2021; 59():215-237. PubMed ID: 34050869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of models for IP3 receptor kinetics using stochastic simulations.
    Hituri K; Linne ML
    PLoS One; 2013; 8(4):e59618. PubMed ID: 23630568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TRPC channel interactions with calmodulin and IP3 receptors.
    Zhu MX; Tang J
    Novartis Found Symp; 2004; 258():44-58; discussion 58-62, 98-102, 263-6. PubMed ID: 15104175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of and chromogranin effect on inositol 1,4,5-trisphosphate sensitivity of cytoplasmic and nucleoplasmic inositol 1,4,5-trisphosphate receptor/Ca2+ channels.
    Huh YH; Kim KD; Yoo SH
    Biochemistry; 2007 Dec; 46(49):14032-43. PubMed ID: 17997581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thimerosal stimulates Ca2+ flux through inositol 1,4,5-trisphosphate receptor type 1, but not type 3, via modulation of an isoform-specific Ca2+-dependent intramolecular interaction.
    Bultynck G; Szlufcik K; Kasri NN; Assefa Z; Callewaert G; Missiaen L; Parys JB; De Smedt H
    Biochem J; 2004 Jul; 381(Pt 1):87-96. PubMed ID: 15015936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A structure-based computational model of IP
    Greene D; Shiferaw Y
    Biophys J; 2024 May; 123(10):1274-1288. PubMed ID: 38627970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mapping Interpuff Interval Distribution to the Properties of Inositol Trisphosphate Receptors.
    Cao P; Falcke M; Sneyd J
    Biophys J; 2017 May; 112(10):2138-2146. PubMed ID: 28538151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploration of inositol 1,4,5-trisphosphate (IP
    Chandran A; Chee X; Prole DL; Rahman T
    Sci Rep; 2019 Feb; 9(1):2454. PubMed ID: 30792485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.